期刊文献+

新辅助化疗对宫颈癌Nanog,Twist表达的影响及临床意义 被引量:1

The effect of Neoadjuvant Chemotherapy on Nanog,Twist Expression in Cervical Cancer and Its Clinical Significance
暂未订购
导出
摘要 目的了解新辅助化疗(NACT)对宫颈癌的近期疗效,分析NACT前后Nanog,Twist表达变化并研究其临床意义。方法应用免疫组化染色的方法检测正常宫颈、CIN、宫颈癌活检及NACT后宫颈癌标本中Nanog与Twist的表达。结果 Nanog,Twist在正常宫颈、CIN及宫颈癌中表达阳性率依次升高,分别为10%,65%,84%和13.3%,45%,66%.Nanog,Twist在NACT后宫颈癌有效组及无效组的表达阳性率分别为30%和70%,20%和80%.结论Nanog,Twist在宫颈癌发生、发展中起重要作用,且可能参与宫颈癌多药耐药形成。 Objective To observed the effect of neoadjuvant chemotherapy ( NACT) on cervical cancer and to,analysis the differences of NACT Nanog ,Twist expression between before and after the NACT .Methods Immunohis-tochemical staining was used to detect the expression of Nanog and Twist among normal cervix ,CIN,cervical biopsy and cervical cancer specimens after NACT.Results From the normol cervix to Cervical Cancer ,The expression of Nanog, Twist were increased:10%,65%,84%,13 .3%,45%,66%.The positive expression of Nanog ,Twist in two groups were 30%and 70%,20%and 80% respectively.Conclusion Nanog,Twist plays an important role during cervical cancer occurrence and development ,and may be involved in the formation of cancer multidrug resistance .
作者 刘莉 马丽丽
出处 《潍坊医学院学报》 2013年第6期465-467,共3页 Acta Academiae Medicinae Weifang
关键词 宫颈肿瘤 免疫组织化学 NACT NANOG TWIST Cervical cancer Immunohistochemistry NACT Nanog Twist
  • 相关文献

参考文献1

二级参考文献30

  • 1[1]Clements WM,Wang J,Sarnaik A,Kim OJ,MacDonald J,Fenoglio-Preiser C,Groden J,Lowy AM.beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.Cancer Res 2002; 62:3503-3506
  • 2[2]Offerhaus GJ,Giardiello FM,Krush AJ,Booker SV,Tersmette AC,Kelley NC,Hamilton SR.The risk of upper gastrointestinal cancer in familial adenomatous polyposis.Gastroenterology 1992; 102:1980-1982
  • 3[3]Nakatsuru S,Yanagisawa A,Ichii S,Tahara E,Kato Y,Nakamura Y,Horii A.Somatic mutation of the APC gene in gastric cancer:frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma.Hum Mol Genet 1992; 1:559-563
  • 4[4]Park WS,Oh RR,Park JY,Lee SH,Shin MS,Kim YS,Kim SY,Lee HK,Kim PJ,Oh ST,Yoo NJ,Lee JY.Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer.Cancer Res 1999; 59:42574260
  • 5[5]Thiery JP.Epithelial-mesenchymal transitions in tumour progression.Nat Rev Cancer 2002; 2:442454
  • 6[6]Huber MA,Kraut N,Beug H.Molecular requirements for epithelial-mesenchymal transition during tumor progression.Curr Opin Cell Biol 2005; 17:548-558
  • 7[7]Kang Y,Massague J.Epithelial-mesenchymal transitions:twist in development and metastasis.Cell 2004; 118:277-279
  • 8[8]Yang J,Mani SA,Donaher JL,Ramaswamy S,ltzykson RA,Come C,Savagner P,Gitelman I,Richardson A,Weinberg RA.Twist,a master regulator of morphogenesis,plays an essential role in tumor metastasis.Cell 2004; 117:927-939
  • 9[9]Maestro R,Dei Tos AP,Hamamori Y,Krasnokutsky S,Sartorelli V,Kedes L,Doglioni C,Beach DH,Hannon GJ.Twist is a potential oncogene that inhibits apoptosis.Genes Dev 1999; 13:2207-2217
  • 10[10]van Doom R,Dijkman R,Vermeer MH,Out-Luiting JJ,van der Raaij-Helmer EM,Willemze R,Tensen CP.Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis.Cancer Res 2004; 64:5578-5586

共引文献28

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部